Abacus Global Management

We assess a moderate moat built on regulatory licenses, data, and integrated distribution plus servicing. Intangible assets: 70/100. The company’s 49‑state provider licensing, proprietary underwriting/mortality data and a two‑decade operating history create real but not impregnable barriers.

These help underwriting accuracy and originations funnel quality, but are replicable by focused, well‑funded peers over time. Switching costs: 60/100. Fee clients and policy‑servicing mandates can be sticky once embedded; origination relationships with advisors and carriers are valuable but can migrate if pricing and service slip.

Network effects: 35/100. More policies and data can attract more capital, which may attract more policies, but effects are localized and not as self‑reinforcing as payments networks.

Cost advantage: 55/100. Vertical scale in origination, servicing, and fund management plus securitization‑adjacent capabilities lower per‑unit acquisition/servicing costs, though financing costs remain meaningful.

Efficient scale: 60/100. Life settlements are a niche with limited capacity and regulatory complexity; large incumbents can deter new entrants in select sub‑pools, yet no single player controls the market.

Weighting these elements (intangible 35%, switching costs 25%, cost advantage 15%, efficient scale 15%, network effects 10%) yields a composite moat score near 62.

Pricing levers include origination spreads and asset management/performance fees. As AUM scales in funds and securitized pools, fee revenue gains more durability and modest pricing leverage.

The firm discloses management fees of roughly 50 to 200 basis points on certain vehicles and servicing fees on policies and securitized collateral pools, which should be defensible if performance remains strong.

However, the market is still competitive, carriers and advisors have alternatives, and realized trading gains can compress in tighter spread environments. We see room for gradual margin mix‑shift rather than outright price hikes.

Abacus is moving from transactional to recurring, but cash flows still reflect mortality timing and policy lifecycle lumpiness. FY2025 produced $235.2 million in revenue and $36.5 million in GAAP net income; Q1 2026 added $59.4 million of revenue with $7.3 million GAAP net income and operating cash flow of $91.7 million.

Management guides 2026 adjusted net income to $100–$106 million, signaling confidence in fee‑based growth as longevity funds scale. That said, realized gains and policy cash events are inherently uneven, and model transparency depends on actuarial assumptions.

Geographic mix is largely U.S. with a Luxembourg asset‑management hub, both in stable jurisdictions. Overall we view the medium‑term outlook as improving but not yet toll‑booth‑like.

Liquidity and leverage are key watch items. Year‑end 2025 cash was ~$38.1 million with total outstanding debt of ~$405.8 million and $38.8 million of FY2025 interest expense; Q1 2026 reported ~$37.2 million cash and ~$330 million debt.

FY2025 operating cash flow was a use of $25.7 million, but Q1 2026 generated $91.7 million, highlighting volatility as capital cycles through originations and policy events. Fixed‑rate senior notes trade under ABXL, and the company emphasizes asset coverage and saleable policy pools for redemption windows.

While we do not see immediate balance‑sheet distress, the model is not fortress‑like and would be tested by adverse mortality/valuation shifts or funding markets tightening.

Positives: the firm initiated a $0.20 dividend for 2025 and has been active with multi‑tranche buyback authorizations that left about $4.2 million available at year‑end 2025, and it is consolidating distribution and asset‑management capability with acquisitions (Carlisle, FCF Advisors, AccuQuote) and a minority stake in Manning & Napier to broaden product and distribution.

Negatives: stock‑based compensation remains material; a 2026 equity plan seeks 17 million shares plus a three‑year evergreen of up to 5 percent per year, and executive RSU/bonus opportunities rose notably in March 2026. Related‑party elements in prior brokerage acquisition require ongoing governance scrutiny.

Net‑net, we see capable strategic moves mixed with dilution and complexity; discipline will need to be proven over time.

Leadership has built a differentiated position in a specialized asset class and is communicating multi‑year targets toward a more recurring revenue mix. Recent appointments elevated operating and investment leaders, reflecting scaling needs.

Still, compensation actions and the equity plan proposal tilt aggressive, and the March 2026 auditor change, though disclosed as without disagreements, adds a caution flag until a KPMG audit cycle is completed. We view execution as solid but governance posture as mixed, warranting a mid‑range score.